Published in Eur J Med Res on April 16, 2009
'Not Until I'm Absolutely Half-Dead and Have To:' Accounting for Non-Use of Antiretroviral Therapy in Semi-Structured Interviews with People Living with HIV in Australia. AIDS Patient Care STDS (2015) 1.07
Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1. Retrovirology (2015) 0.79
Strategies adopted by late middle-age and older adults with HIV/AIDS to explain their physical symptoms. Psychol Health (2011) 0.77
Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann Intern Med (2003) 4.46
Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr (2002) 4.39
Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med (2005) 2.38
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01
Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med (2006) 1.97
Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res (2008) 1.97
Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis (2004) 1.94
Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials (2001) 1.71
Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci (2007) 1.49
Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol (2000) 1.47
Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team. J Acquir Immune Defic Syndr (2000) 1.45
Sex differences in antiretroviral therapy-associated intolerance and adverse events. Drug Saf (2005) 1.35
National estimates of HIV-related symptom prevalence from the HIV Cost and Services Utilization Study. Med Care (2000) 1.34
Sex differences in pharmacokinetics and toxicity of antiretroviral therapy. Expert Opin Drug Metab Toxicol (2006) 1.29
The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART. AIDS Behav (2003) 1.25
Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr (2003) 1.25
To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care STDS (2006) 1.24
Sex differences in adverse reactions to antiretroviral drugs. Top HIV Med (2003) 1.17
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification. Antivir Ther (2007) 1.14
Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clin Infect Dis (2008) 1.01
Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. J Womens Health (Larchmt) (2006) 0.96
Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center. J Acquir Immune Defic Syndr (1999) 0.95
Kidney disease in the HIV-infected patient. AIDS Patient Care STDS (2007) 0.93
Recreational use of sildenafil by HIV-positive and -negative homosexual/bisexual males. Ann Pharmacother (2004) 0.89
HIV-therapy associated lipodystrophy: experimental and clinical evidence for the pathogenesis and treatment. Endocr Metab Immune Disord Drug Targets (2007) 0.86
Causal attributions for fatigue among late middle-aged and older adults with HIV infection. J Pain Symptom Manage (2004) 0.85
The fatigue experience: persons with HIV infection. J Adv Nurs (1998) 0.82
Clinical vignette in antiretroviral therapy: jaundice. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.79
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet (1998) 4.54
Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol (1997) 2.59
Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol (2002) 2.03
Soluble cerebrospinal fluid factors induce Ca2+ dysregulation in rat cultured cortical astrocytes in HIV-1-associated dementia complex. AIDS (2001) 2.01
Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study. Clin Infect Dis (2008) 1.81
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer (1997) 1.65
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? Ann Rheum Dis (2009) 1.59
Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med (1996) 1.58
The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes. Immunology (1975) 1.51
Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci U S A (1992) 1.47
ARFI elastography of the spleen is inferior to liver elastography for the detection of portal hypertension. Ultraschall Med (2011) 1.46
HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol (2000) 1.44
Fatal hepatic failure with liposomal doxorubicin. Lancet (1993) 1.41
Comparison of anal sonography with conventional needle electromyography in the evaluation of anal sphincter defects. Am J Gastroenterol (1996) 1.40
HPV-73- and HPV-82 positive anal margin carcinoma with secondary ulcerating Herpes simplex-virus 2 infection. J Dtsch Dermatol Ges (2010) 1.38
First confirmed autochthonous case of human Babesia microti infection in Europe. Eur J Clin Microbiol Infect Dis (2007) 1.33
Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene (1995) 1.29
Diagnosing patients with longstanding shoulder joint pain. Ann Rheum Dis (2002) 1.27
A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol (2004) 1.24
Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis (2005) 1.15
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis (2008) 1.13
Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. Br J Dermatol (2010) 1.09
Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes--evidence for polygenicity in man. Danish Study Group of Diabetes in Childhood. Autoimmunity (1994) 1.06
Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. J Invest Dermatol (2008) 1.05
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis (2010) 1.05
The control of immune response in vitro by Ca2+. II. The Ca2+-dependent period during mitogenic stimulation. Immunology (1975) 1.03
Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. Br J Pharmacol (2007) 1.02
On the pathogenesis of IDDM. Diabetologia (1994) 1.02
p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load. Br J Dermatol (2007) 1.02
Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. J Invest Dermatol (2008) 1.00
Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration. Eur J Neurol (2012) 1.00
Pharmacokinetic and pharmacodynamic analysis of efavirenz dose reduction using an in vitro-in vivo extrapolation model. Clin Pharmacol Ther (2012) 1.00
Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings. Arch Neurol (2000) 0.97
["Catastrophic systemic lupus erythematosus" with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20/rutuximab]. Dtsch Med Wochenschr (2001) 0.97
Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology (2007) 0.96
Substance use and sexual risk behaviour among HIV-positive men who have sex with men in specialized out-patient clinics. HIV Med (2012) 0.96
Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy. J Infect Dis (2009) 0.95
Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study. Ann Rheum Dis (2009) 0.94
Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Antivir Ther (2007) 0.94
Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses. J Neural Transm (Vienna) (2010) 0.94
Frequency and topographical distribution of CD68-positive macrophages and HIV-1 core proteins in HIV-associated brain lesions. Clin Neuropathol (1994) 0.92
Bacillary angiomatosis in HIV-infected patients--an epidemiological and clinical study. Dermatology (2000) 0.92
Skin disorders in association with monoclonal gammopathies. Eur J Med Res (2005) 0.92
Limited value of PCR for detection of Toxoplasma gondii in blood from human immunodeficiency virus-infected patients. J Clin Microbiol (1997) 0.91
Ultrasonography in the assessment of peripheral joint involvement in psoriatic arthritis : a comparison with radiography, MRI and scintigraphy. Clin Rheumatol (2008) 0.91
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort. Eur J Med Res (2009) 0.91
Post-hypoxic action (intention) myoclonus: a clinico-electroencephalographic study. J Neurol (1988) 0.91
Early microstructural white matter changes in patients with HIV: a diffusion tensor imaging study. BMC Neurol (2012) 0.91
Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress. HIV Med (2011) 0.91
Haemodynamic effects of eating: the role of meal composition. Clin Sci (Lond) (1996) 0.91
Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease. J Neurovirol (2007) 0.90
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain. Curr Med Res Opin (2013) 0.90
Patients with fibromyalgia benefit from aerobic endurance exercise. Clin Rheumatol (2000) 0.89
Tenofovir-induced osteomalacia. Clin Exp Rheumatol (2010) 0.89
The Patient Cohort of the German Competence Network for HIV/AIDS (KompNet): a profile. Eur J Med Res (2009) 0.89
Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced? Ann Rheum Dis (2008) 0.89
German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004). Eur J Med Res (2004) 0.89
Epidemiological composition, clinical and treatment characteristics of the patient cohort of the German Competence Network for HIV/AIDS. Eur J Med Res (2009) 0.89
Anal intraepithelial neoplasia in HIV infection. J Dtsch Dermatol Ges (2008) 0.88
Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1. Arch Neurol (2001) 0.88
The formation of B-lymphocyte colonies in agar contained in glass capillaries. Immunology (1978) 0.88
Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology (2002) 0.87
Human papillomavirus-associated induction of human beta-defensins in anal intraepithelial neoplasia. Br J Dermatol (2009) 0.87
Two distinct lumphocyte-stimulating soluble factors (LAF) released from murine peritoneal cells. I. The cellular source and the effect of cGMP on their release. Immunology (1976) 0.87
A manganese superoxide dismutase (SOD2) gene polymorphism in insulin-dependent diabetes mellitus. Dis Markers (1993) 0.87
Focal brain lesions in patients with AIDS: aetiologies and corresponding radiological patterns in a prospective study. J Neurol (1995) 0.86
Stimulation by cyclic GMP of lymphocytes mediated by soluble factor released from adherent cells. Nature (1975) 0.86
Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count. Infection (1998) 0.86
Treatment of chronic relapsing inflammatory demyelinating polyneuropathy by cyclosporin A and plasma exchange. A case report. J Neurol (1990) 0.86
Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines. Vaccine (2009) 0.86
Unusual presentation of fibroma of tendon sheath. Dermatology (2007) 0.85
Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion. Antimicrob Agents Chemother (2008) 0.85
Diagnostic criteria and clinical procedures in HIV-1 associated progressive multifocal leukoencephalopathy. J Neurol Sci (1997) 0.85
Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men. Br J Dermatol (2010) 0.85
Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann Rheum Dis (2011) 0.84
Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection. Br J Nutr (1996) 0.84
Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices. Eur J Clin Nutr (2007) 0.84
Dapsone in the management of "insect bite-like reaction" in a patient with chronic lymphocytic leukaemia. Br J Dermatol (2007) 0.84
[Emergency heart valve replacement after acute cerebral embolism during florid endocarditis]. Med Klin (Munich) (1998) 0.84
Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction. PLoS One (2012) 0.84
Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil. Br J Dermatol (2002) 0.84
Versican overexpression in cutaneous malignant melanoma. Eur J Med Res (2008) 0.84
Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty. Eur Heart J (1994) 0.84
Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV. J Neurol (2009) 0.83
Development of a novel monoclonal antibody to B7-H4: characterization and biological activity. Eur J Med Res (2011) 0.83
Kaposi sarcoma in a HIV uninfected man who has sex with men. Eur J Med Res (2010) 0.83
Liposomal doxorubicin in AIDS-related Kaposi's sarcoma. Lancet (1993) 0.83
MR characterization of cardiac abnormalities in HIV+ individuals with increased BNP levels. Eur J Med Res (2007) 0.83
Regulation of DNA synthesis by guanosine-5'-diphosphate, cyclic guanosine-3',5'-monophosphate, and cyclic adenosine-3', 5'-monophosphate in mouse lymphoid cells. Exp Cell Res (1975) 0.83
GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma. Eur J Med Res (2010) 0.83